Investing
Cathie Wood's ARK Invest Sells Over 60,000 Shares of Pluristem Therapeutics
Published:
One ARK Invest exchange-traded fund run by ETF star Cathie Wood sold over 62,000 shares of Pluristem Therapeutics Inc. (NASDAQ: PSTI) on Tuesday, as the share price of this fund traded up less than 1% in the day’s session. That share price has greatly improved over the past year.
ARK Genomic Revolution ETF (NYSEARCA: ARKG) sold 62,738 shares of Pluristem. At Tuesday’s closing price, this would have valued this sale at roughly $252,000. This is only a small fraction of the total holdings. This fund is up 84% over the past 52 weeks.
Here is a quick look at all the other sales that took place across all ARK ETFs:
Fund | Ticker | Company | Shares |
---|---|---|---|
ARKG | CSTL | Castle Biosciences | 4,800 |
ARKG | PSTI | Pluristem Therapeutics | 62,738 |
ARKQ | GLEO | Galileo Acquisition | 1,798 |
ARKQ | RAVN | Raven Industries | 8,104 |
ARKW | LC | LendingClub | 82 |
ARKW | PD | PagerDuty | 6,567 |
ARKW | ROKU | Roku | 5,986 |
ARKW | SE | Sea | 21,337 |
Catherine Wood, the CEO and CIO of ARK Investment Management, is a minority and nonvoting shareholder of 24/7 Wall St.
The Average American Is Losing Momentum On Their Savings Every Day (Sponsor)
If you’re like many Americans and keep your money ‘safe’ in a checking or savings account, think again. The average yield on a savings account is a paltry .4%1 today. Checking accounts are even worse.
But there is good news. To win qualified customers, some accounts are paying more than 7x the national average. That’s an incredible way to keep your money safe and earn more at the same time. Our top pick for high yield savings accounts includes other benefits as well. You can earn a $200 bonus and up to 7X the national average with qualifying deposits. Terms apply. Member, FDIC.
Click here to see how much more you could be earning on your savings today. It takes just a few minutes to open an account to make your money work for you.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.